ABT Stock Quote Price and Forecast | CNN

ABT

Abbott Laboratories

Key terms

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Yesterday 9:58am ET ABT Earnings: Abbott Beats Expectations with Q1 Earnings by TipRanks Yesterday 7:05am ET Options Volatility and Implied Earnings Moves Today, April 17, 2024 by TipRanks Yesterday 3:59am ET RBC Capital Remains a Buy on Abbott Labs (ABT) by TipRanks Apr 16 8:25pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 16 1:13pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 16 1:13pm ET Notable companies reporting before tomorrow’s open by TipRanks Apr 15 7:00am ET Options Volatility and Implied Earnings Moves This Week, April 15 – April 19, 2024 by TipRanks Apr 04 4:08am ET Buy Rating Reaffirmed for Abbott Labs Amid Strong Growth and New Product Launches by TipRanks Apr 03 5:50am ET Abbott price target raised to $128 from $126 at Citi by TipRanks Apr 02 7:05pm ET Buy Rating Affirmed for Abbott Labs Following TriClip’s Favorable FDA Approval and Market Outlook by TipRanks Apr 02 9:01am ET Abbott receives FDA approval for TriClip by TipRanks Apr 01 9:02am ET Abbott announces FDA clearance of i-STAT TBI cartridge by TipRanks Mar 26 4:47am ET Abbott Labs (ABT) Gets a Buy from Wells Fargo by TipRanks Mar 12 5:20am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT) by TipRanks Mar 11 3:49pm ET FDA reports Abbott recalls HeartMate Touch Communication System by TipRanks Mar 07 5:56am ET Abbott Labs (ABT) Gets a Buy from Wells Fargo by TipRanks Mar 06 9:03am ET Abbott announces new data from studies with GLP-1 medicines and Freestyle Libre by TipRanks Feb 29 6:50am ET Analysts Offer Insights on Healthcare Companies: Sensei Biotherapeutics (SNSE), Abbott Labs (ABT) and Personalis (PSNL) by TipRanks Feb 26 6:30am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Abbott Labs (ABT) and Morphic Holding (MORF) by TipRanks Feb 13 6:54pm ET Abbott announces FDA voted in favor of its TriClip System by TipRanks Feb 12 5:50am ET Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Embecta Corporation (EMBC) and Abbott Labs (ABT) by TipRanks Feb 09 1:55pm ET Positive Outlook for Abbott Labs on TriClip Device Efficacy and Anticipated FDA Approval by TipRanks Feb 08 6:39am ET ABT, PEP: 2 Dividend Aristocrat Stocks Hedge Funds are Bullish On by TipRanks Feb 07 6:10am ET Insulet gets CE Mark approval of Omnipod 5 integration with FreeStyle Libre 2 by TipRanks Feb 02 10:48am ET Wells upgrades Edwards Lifesciences, says tricuspid opportunity underappreciated by TipRanks Feb 02 6:40am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Labs (ABT), Sanofi (OtherSNYNF) and Siemens Healthineers AG (OtherSEMHF) by TipRanks Feb 01 9:06am ET Abbott’s mixed reality technology improves blood donor experience by TipRanks Jan 31 6:03pm ET LLY, ABT, CVS: Which Healthcare Stock Do Analysts Prefer? by TipRanks Jan 31 9:05am ET Abbott launches its new PROTALITY brand by TipRanks Jan 28 9:10pm ET Analysts’ Top Healthcare Picks: Abbott Labs (ABT), eFFECTOR Therapeutics (EFTR) by TipRanks Jan 26 5:43am ET Abbott price target raised to $141 from $133 at Barclays by TipRanks

Mar 15 8:30am ET Diabetes and Heart Disease: How to Manage Your Risk by Accesswire

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.

Frank Franklin II/AP

Trump Media stock ends session 15% higher after two very bad days

Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.

Patrick Reddy/The Enquirer/AP/File

Private equity finds its next bet: college admissions

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.

Scott Olson/Getty Images

Trump’s stock tumbles again after Truth Social announces it’s getting into streaming

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images

Samuel Corum/Bloomberg/Getty Images

Geopolitical strife is roiling Wall Street. Here’s what investors are watching